The promise of gene expression analysis in hematopoetic malignancies.
Radich
Jerald P
JP
Clinical Research Division, Program in Genetics and Genomics, Fred Hutchinson Cancer Research Center, D4-100, 1100 Fairview Ave N., Seattle, WA 98109, USA. jradich@fhcrc.org
D000818:Animals; D001549:Benzamides; D016172:DNA Fingerprinting; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D019337:Hematologic Neoplasms / Q000145:classification* / Q000188:drug therapy / Q000235:genetics; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000145:classification; D016403:Lymphoma, Large B-Cell, Diffuse / Q000145:classification; D009190:Myelodysplastic Syndromes / Q000145:classification; D020411:Oligonucleotide Array Sequence Analysis; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use
D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate